The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index; none of the 41 sources its claims cite is checked for support yet.
Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels
Open accessAbstract
Metabolic reprogramming is emerging as a hallmark of the innate immune response, and the dynamic control of metabolites such as succinate serves to facilitate the execution of inflammatory responses in macrophages and other immune cells. Immunoresponsive gene 1 (Irg1) expression is induced by inflammatory stimuli, and its enzyme product cis-aconitate decarboxylase catalyzes the production of itaconate from the tricarboxylic acid cycle. Here we identify an immunometabolic regulatory pathway that links Irg1 and itaconate production to the succinate accumulation that occurs in the context of innate immune responses. Itaconate levels and Irg1 expression correlate strongly with succinate during LPS exposure in macrophages and non-immune cells. We demonstrate that itaconate acts as an endogenous succinate dehydrogenase inhibitor to cause succinate accumulation. Loss of itaconate production in activated macrophages from Irg1(-/-) mice decreases the accumulation of succinate in response to LPS exposure. This metabolic network links the innate immune response and tricarboxylic acid metabolism to function of the electron transport chain.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This paper identifies an immunometabolic pathway in which Irg1/CAD-derived itaconate inhibits succinate dehydrogenase (SDH), causing succinate accumulation during LPS exposure. Loss of Irg1 in macrophages reduces itaconate and succinate, linking innate immune metabolism to TCA cycle and electron transport chain function.
Key findings
- In LPS-activated RAW 264.7 macrophages, itaconate and succinate levels showed similar trends over 6 h, unlike citrate, α-ketoglutarate, fumarate, and malate; basal oxygen consumption rate remained unchanged.
- Exogenous itaconate (0–25 mM, 6 h) increased intracellular itaconate dose-dependently and correlated strongly with succinate in resting and LPS-activated RAW 264.7 macrophages (r = 0.99) and in A549 cells (r = 0.99), while other TCA intermediates correlated poorly or negatively.
- Itaconate was not metabolized to succinate: [1-13C]glutamine labeling produced ~65% M1 itaconate but no succinate labeling, and prelabeling with [U-13C6]glucose/[U-13C5]glutamine left succinate labeling ~90% after unlabeled itaconate.
- Itaconate inhibited SDH/complex II: dose-dependent OCR inhibition in permeabilized RAW 264.7 macrophages and BMDMs with succinate, >75% reduction with 10 mM itaconate plus succinate/rotenone, and no effect on complex I or IV substrates; Irg1 KO BMDMs failed to produce itaconate and had significantly lower succinate than WT after LPS, while Irg1 overexpression in A549 cells increased succinate.
Methods
- Cell models and treatments: RAW 264.7 macrophages, A549 lung adenocarcinoma cells, and primary BMDMs from C57BL/6J and Irg1 KO mice; LPS at 10 ng/ml; itaconate at 5, 10, and 25 mM for 6 h; A549 cells transfected with pCMV6-Irg1 or empty vector.
- Metabolite and isotope analysis: GC-MS quantification of itaconate and TCA intermediates using external standard curves; isotopic labeling with [1-13C]glutamine, [U-13C6]glucose, and [U-13C5]glutamine; mass isotopomer distributions corrected for natural abundance.
- Respiration and statistics: Seahorse XF96 oxygen consumption measurements in intact and permeabilized cells (perfringolysin O) with succinate/rotenone, glutamate/malate, pyruvate/malate, or ascorbate/TMPD/antimycin A; Pearson correlation and two-tailed Student’s t tests.
Limitations
- Stated: The authors note variability in succinate accumulation between RAW 264.7 macrophages and BMDMs, likely due to cell, medium, and LPS variability; they also state that the physiological role of itaconate and Irg1 requires further investigation, particularly in macrophage development and differentiation.
- Stated: It is not known whether downstream inflammatory responses are mediated directly by succinate or itaconate or through other mechanisms; no mammalian mitochondrial or plasma membrane itaconate transporters have been described, and other succinate-producing pathways (GABA shunt, glutaminolysis) could compensate.
- Evident from the text: Most mechanistic experiments use cultured cells and exogenous itaconate up to 25 mM, whereas endogenous macrophage itaconate is cited as up to 8 mM; no in vivo inflammation or disease model is presented.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 41 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We observed a dose depen- dent inhibition of OCRs by itaconate in RAW 264.7 macrophages (Fig. 5a) and BMDMs (Fig. 5b)”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Itaconate and Irg1-induced Succinate Accumulation Is Not
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Itaconate also failed to impact this complex IV-mediated respiration.”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Itaconate and Irg1-induced Succinate Accumulation Is Not
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Notably, basal oxygen consumption rates (OCR) remained unchanged compared with resting macrophages (Fig. 1b).”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Succinate and Itaconate Accumulate in LPS-activated RAW 264.7 Macrophages-To better understand the relationship between
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, medium itaconate levels were not appreciably affected (Fig. 2g).”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Succinate and Itaconate Accumulate in LPS-activated RAW 264.7 Macrophages-To better understand the relationship between
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Because labeling of succinate after exposure to exogenous, unlabeled itaconate was unchanged (even in the physi-ological concentration used here) (Fig. 4d)”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Itaconate and Irg1-induced Succinate Accumulation Is Not
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we observed that intracellular itaconate levels correlated strongly with succinate levels in resting (r ϭ 0.99) as well as LPS-activated macrophages (r ϭ 0.99)”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Succinate and Itaconate Accumulate in LPS-activated RAW 264.7 Macrophages-To better understand the relationship between
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Intriguingly, the levels of itaconate and succinate exhibited similar trends upon activation, in contrast to the dynamics of citrate, ␣-ketoglutarate, fumarate, and malate (Fig. 1a)”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Succinate and Itaconate Accumulate in LPS-activated RAW 264.7 Macrophages-To better understand the relationship between
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the levels of other TCA intermediates, including citrate, ␣-ketoglutarate, fumarate, and malate correlated poorly (or in some cases negatively) with intracellular itaconate levels (Fig. 2, a, b, d, and f).”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Succinate and Itaconate Accumulate in LPS-activated RAW 264.7 Macrophages-To better understand the relationship between
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Loss of itaconate production in activated macrophages from Irg1 ؊/؊ mice decreases the accumulation of succinate in response to LPS exposure.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“oxygen consumption rates in permeabilized cells in the presence of either pyruvate with malate or glutamate with malate, substrates that drive respiration via complex I activity, were not affected by itaconate supplementation.”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Itaconate and Irg1-induced Succinate Accumulation Is Not
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 10
- Probably not a substantial claim. 13
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Succinate levels increased linearly with itaconate levels and correlated strongly (r ϭ 0.99), whereas other TCA cycle intermediates, including citrate, ␣-ketoglutarate, fumarate, and malate, did not accumulate (Fig. 3a).”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Itaconate and Irg1-induced Succinate Accumulation Is Not
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although we observed high fractions of M1 itaconate isotopologues (ϳ65%) because of itaconate production via reductive glutamine metabolism, no labeling was detected on succinate (Fig. 4b).”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Itaconate and Irg1-induced Succinate Accumulation Is Not
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“exposure to exogenous itaconate induces succinate accumulation in resting RAW 264.7 macrophages (Fig. 2e) as well as resting BMDMs (Fig. 2h)”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Succinate and Itaconate Accumulate in LPS-activated RAW 264.7 Macrophages-To better understand the relationship between
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Within our analyses, we did observe variability in succinate accumulation upon LPS stimulation when comparing RAW 264.7 macrophages and BMDMs.”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Discussion
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“The first break occurs at isocitrate dehydrogenase, leading to the accumulation of citrate, the precursor for itaconate”
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Although itaconate has been shown previously to inhibit SDH ex vivo (26 -28)”
What the sources say
- Not checked yetcites [26] Booth, 1952, The inhibitory effects of itaconic acid in vitro and in vivo, J. Biol. Chem. source
- Not checked yetcites [27] Ackermann, 1949, Enzyme inhibition in relation to chemotherapy, Proc. Soc. Exp. Biol. Med. source
- Not checked yetcites [28] Dervartanian, 1964, Studies on succinate dehydrogenase: I: spectral properties of the purified enzyme and formation of enzyme-competitive inhibitor complexes, Biochim. Biophys. Acta.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“although glycolytic metabolism is a prerequisite (14).”
What the sources say
- Not checked yetcites [14] Palsson-McDermott, 2015, Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages, Cell Metab source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“the second break occurs at succinate dehydrogenase (SDH), which may allow for succinate accumulation.”
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The emerging role of itaconate as a regulatory molecule to reprogram immune cell metabolism provides an intriguing link between innate immunity, metabolism, and disease pathogenesis.”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Discussion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
- Rests on an assumption: The cell models used are representative of macrophages in vivo for conclusions about immune cell metabolism.
In the paper
“Itaconate was only recently identified as an endogenous mammalian biochemical (19), and subsequent studies demonstrated that this molecule was produced by mammalian CAD activity on cis-aconitate (20).”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Discussion
What the sources say
- Not checked yetcites [20] Michelucci, 2013, Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production, Proc. Natl. Acad. Sci. U.S.A source
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Numerous metabolic pathways have been implicated in the metabolic reprogramming of immune cells, in particular those that regulate succinate levels, which, in turn, can influence HIF signaling or other pathways (13,25,40,41).”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Discussion
What the sources say
- Not checked yetcites [13] Mills, 2014, Succinate: a metabolic signal in inflammation, Trends Cell Biol source
- Not checked yetcites [25] Jha, 2015, Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization, Immunity source
- Not checked yetcites [40] Chouchani, 2016, A unifying mechanism for mitochondrial superoxide production during ischemia-reperfusion injury, Cell Metab source
- Not checked yetcites [41] Chouchani, 2014, Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS, Nature source
Strength:plain· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Intracellular signaling pathways also play key roles in macrophage polarization and likely sustain inflammation to some degree in the absence of Irg1 (44).”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Discussion
What the sources say
- Not checked yetcites [44] Sica, 2012, Macrophage plasticity and polarization: in vivo veritas, J. Clin. Invest. source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Glutamine serves as a major carbon source for succinate production in LPSactivated macrophages via ␣-ketoglutarate or, alternatively, through the GABA shunt (9).”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Discussion
What the sources say
- Not checked yetcites [9] Tannahill, 2013, Succinate is an inflammatory signal that induces IL-1β through HIF-1α, Nature source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“This variance is in the range of succinate accumulation levels reported by others and is likely a function of cell, medium formulation, and LPS variability (9).”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Discussion
What the sources say
- Not checked yetcites [9] Tannahill, 2013, Succinate is an inflammatory signal that induces IL-1β through HIF-1α, Nature source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As such, itaconate may have pleiotropic effects on cells depending on the expression, K i , and compartment-specific impacts on succinate concentrations.”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Discussion
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“As noted above, various other pathways (e.g.GABA shunt, glutaminolysis) contribute to succinate synthesis in macrophages and could allow compensation (9, 13, 14).”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Discussion
What the sources say
- Not checked yetcites [9] Tannahill, 2013, Succinate is an inflammatory signal that induces IL-1β through HIF-1α, Nature source
- Not checked yetcites [13] Mills, 2014, Succinate: a metabolic signal in inflammation, Trends Cell Biol source
- Not checked yetcites [14] Palsson-McDermott, 2015, Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages, Cell Metab source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Given the regulatory role of itaconate in succinate accumulation described here, IRG1-mediated itaconate production may act as a signaling molecule in other inflammatory situations or cellular states.”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Discussion
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✗ Checkable: fails✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. It may be too vague to check against evidence. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Taken together, our data highlight a mechanistic function of itaconate whereby this metabolite acts as a SDH inhibitor to influence TCA cycle metabolism by driving succinate accumulation (Fig. 7).”
- Also stated in: § Discussion · plain
“This metabolite contributes to succinate accumulation in macrophages by acting as an endogenous SDH inhibitor.”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Loss of Irg1 Influences Succinate Levels in
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Discussion · plain
None of the sources cited for this claim have been checked yet.
In the paper
“Succinate inhibits HIF-1␣ signaling through inhibition of PHD2 but can also impact the activity of numerous ␣-ketoglutarate-dependent dioxygenases (42,43).”
§ Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels * > Discussion
What the sources say
- Not checked yetcites [42] Xiao, 2012, Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors, Genes Dev source
- Not checked yetcites [43] Metallo, 2013, Understanding metabolic regulation and its influence on cell physiology, Mol. Cell. source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper relies on this without support.
The specific driver(s) of succinate accumulation in inflammatory macrophages have not yet been identified.
“However, the specific driver(s) of this phenomenon has/have not yet been identified.”
The paper relies on this without support.
A potential role of endogenously produced itaconate in succinate accumulation under inflammatory conditions has not yet been addressed and is unknown.
“a potential role of endogenously produced itaconate in succinate accumulation under inflammatory conditions has not yet been addressed and is unknown.”
The paper relies on this without support.
The Irg1 KO mouse model specifically abolishes itaconate production without other metabolic adaptations that affect succinate levels.
“Notably, succinate concentrations in stimulated BMDMs from Irg1 KO mice were significantly lower than those quantified in BMDMs from WT mice, suggesting that CAD-derived itaconate influences succinate accumulation in LPS-induced macrophages (Fig. 6c).”
The paper relies on this without support.
The effects of exogenous itaconate on succinate accumulation reflect the physiological role of endogenous itaconate.
“In the cells studied, exogenous and endogenous, CAD-produced itaconate strongly correlated with succinate accumulation.”
The paper relies on this without support.
The cell models used are representative of macrophages in vivo for conclusions about immune cell metabolism.
“However, we consistently observed increased succinate downstream of itaconate production or administration in a variety of cell types.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mechanistically LDHA-deficient T cells showed decreased acetyl-CoA levels and decreased histone H3 acetylation at the lysine 9 residue (H3K9Ac), a histone mark associated with active transcription, on the Ifng promoter.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [55]
In the citing paper
“Mice with an T cell-specific LDHA deficiency produced less IFN-γ and were protected from immunopathology.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [55]
In the citing paper
“The authors demonstrate that LDA, an enzyme that catalyzes the reversible conversion of pyruvate and NADH to lactate and NAD+, is induced in activated T cells and enhances histone acetylation of interferon gamma (Ifng) via the maintenance of acetyl-CoA levels to promote its expression 55.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [55]
In the citing paper
“Furthermore, artificial acetyl-CoA reduction, through inhibition of ACLY, decreased IFN-γ expression and acetate supplementation, which augmented acetyl-CoA production, corrected H3K9Ac marks and IFN-γ expression in LDHA-deficient T cells.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [55]
In the citing paper
“The generation of itaconate from the Krebs Cycle intermediate cis-aconitate contrasts with most other metabolite signals emanating from mitochondria, in that it primarily acts as a protective, anti-inflammatory metabolite55,59,60.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Inconsistent itaconate concentrations for respiration assays
MinorThe methods list four itaconate concentrations for the permeabilized-cell respiration assay, but the Figure 5 caption lists five, including 2.5 mM.
“increasing itaconate concentrations (0, 5, 10, and 25 mM)”
“increasing itaconate concentrations (0, 2.5, 5, 10, and 25 mM)”
Opposite claims about succinate's effect on HIF-1α signaling
MinorThe discussion says succinate inhibits HIF-1α signaling, whereas the earlier account says succinate stabilizes HIF-1α and enhances its downstream effect.
“Succinate inhibits HIF-1␣ signaling through inhibition of PHD2”
“succinate acts as a regulatory signal enhancing Il-1 expression through stabilization of HIF-1␣”
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,893
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,976
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS
Chouchani, E. T., Pell, V. R., Gaude, E., Aksentijević, D., Sundier, S. Y., Robb, E. L., Logan, A., Nadtochiy, S. M., Ord, E. N. J., Smith, A. C., et al. (2014) · Nature · doi:10.1038/nature13909 · Cited by 2,907 · cited 3×
“Numerous metabolic pathways have been implicated in the metabolic reprogramming of immune cells, in particular those that regulate succinate levels, which, in turn, can influence HIF signaling or other pathways (13, 25, 40, 41).”
BackgroundGiard, D. J., Aaronson, S. A., Todaro, G. J., Arnstein, P., Kersey, J. H., Dosik, H., & Parks, W. P. (1973) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/51.5.1417 · Cited by 2,336
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108
Jha, A. K., Huang, S. C.-C., Sergushichev, A., Lampropoulou, V., Ivanova, Y., Loginicheva, E., Chmielewski, K., Stewart, K. M., Ashall, J., Everts, B., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.005 · Cited by 2,066
Metabolic reprogramming in macrophages and dendritic cells in innate immunity
Kelly, B., & O'Neill, L. A. (2015) · Cell Research · doi:10.1038/cr.2015.68 · Cited by 1,876
Flagged first, then by citations
Cited by
Sorted by citations
Mitochondrial TCA cycle metabolites control physiology and disease
Martínez-Reyes, I., & Chandel, N. S. (2020) · Nature Communications · doi:10.1038/s41467-019-13668-3 · Cited by 2,813
Defining trained immunity and its role in health and disease
Netea, M. G., Domínguez-Andrés, J., Barreiro, L. B., Chavakis, T., Divangahi, M., Fuchs, E., Joosten, L. A. B., van der Meer, J. W. M., Mhlanga, M. M., Mulder, W. J. M., et al. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0285-6 · Cited by 2,690
Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1
Mills, E. L., Ryan, D. G., Prag, H. A., Dikovskaya, D., Menon, D., Zaslona, Z., Jedrychowski, M. P., Costa, A. S. H., Higgins, M., Hams, E., et al. (2018) · Nature · doi:10.1038/nature25986 · Cited by 1,885
Macrophage Immunometabolism: Where Are We (Going)?
den Bossche, J. V., O'Neill, L. A. J., & Menon, D. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.03.001 · Cited by 1,187
Metabolic reprogramming and epigenetic modifications on the path to cancer
Sun, L., Zhang, H., & Gao, P. (2021) · Protein & Cell · doi:10.1007/s13238-021-00846-7 · Cited by 818
Navigating metabolic pathways to enhance antitumour immunity and immunotherapy
Li, X., Wenes, M., Romero, P. J., Huang, S. C., Fendt, S., & Ho, P. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0203-7 · Cited by 750
Electrophilic properties of itaconate and derivatives regulate the IκBζ–ATF3 inflammatory axis
Bambouskova, M., Gorvel, L., Lampropoulou, V., Sergushichev, A., Loginicheva, E., Johnson, K., Korenfeld, D., Mathyer, M. E., Kim, H., Huang, L.-H., et al. (2018) · Nature · doi:10.1038/s41586-018-0052-z · Cited by 713
Glycolysis – a key player in the inflammatory response
Soto‐Heredero, G., Heras, M. M. G. D. L., Gabandé‐Rodríguez, E., Oller, J., & Mittelbrunn, M. (2020) · FEBS Journal · doi:10.1111/febs.15327 · Cited by 660
Itaconate: the poster child of metabolic reprogramming in macrophage function
O'Neill, L. A. J., & Artyomov, M. N. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0128-5 · Cited by 643
Metabolic Regulation of Macrophage Polarization in Cancer
Mehla, K., & Singh, P. K. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.10.007 · Cited by 621
The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
Hooftman, A., Angiari, S., Hester, S., Corcoran, S. E., Runtsch, M. C., Ling, C., Ruzek, M. C., Slivka, P. F., McGettrick, A. F., Banahan, K., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.07.016 · Cited by 632
Redox regulation of the immune response
Morris, G., Gevezova, M., Sarafian, V. S., & Maes, M. H. J. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00902-0 · Cited by 628
Williams, N. C., & O'Neill, L. A. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00141 · Cited by 599
Metabolism of tissue macrophages in homeostasis and pathology
Wculek, S. K., Dunphy, G., Heras-Murillo, I., Mastrangelo, A., & Sancho, D. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00791-9 · Cited by 501
Palmieri, E. M., Gonzalez-Cotto, M., Baseler, W. A., Davies, L. C., Ghesquière, B., Maio, N., Rice, C. M., Rouault, T. A., Cassel, T., Higashi, R. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14433-7 · Cited by 483
The role of itaconate in host defense and inflammation
Peace, C. G., & O’Neill, L. A. J. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148548 · Cited by 469
Krebs cycle Reborn in macrophage immunometabolism
Ryan, D. G., & O'Neill, L. A. J. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-081619-104850 · Cited by 444
Coupling Krebs cycle metabolites to signalling in immunity and cancer
Ryan, D. G., Murphy, M. P., Frezza, C., Prag, H. A., Chouchani, E. T., O’Neill, L. A., & Mills, E. L. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0014-7 · Cited by 398
Domínguez‐Andrés, J., Novakovic, B., Li, Y., Scicluna, B. P., Gresnigt, M. S., Arts, R. J. W., Oosting, M., Moorlag, S. J. C. F. M., Groh, L. A., Zwaag, J., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.003 · Cited by 403
Self-citationKrebs Cycle Reimagined: The Emerging Roles of Succinate and Itaconate as Signal Transducers
Murphy, M. P., & O'Neill, L. A. J. (2018) · Cell · doi:10.1016/j.cell.2018.07.030 · Cited by 399
Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases
Belizário, J. E., Faintuch, J., & Garay-Malpartida, M. (2018) · Mediators of Inflammation · doi:10.1155/2018/2037838 · Cited by 341
Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation
Billingham, L. K., Stoolman, J. S., Vasan, K., Rodriguez, A. E., Poor, T. A., Szibor, M., Jacobs, H. T., Reczek, C. R., Rashidi, A., Zhang, P., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01185-3 · Cited by 368
Metabolism as a guiding force for immunity
Jung, J., Zeng, H., & Horng, T. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0217-x · Cited by 354
Serine Metabolism Supports Macrophage IL-1β Production
Rodriguez, A. E., Ducker, G. S., Billingham, L. K., Martinez, C. A., Mainolfi, N., Suri, V., Friedman, A. A., Manfredi, M. G., Weinberg, S. E., Rabinowitz, J. D., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.014 · Cited by 349
Swain, A., Bambousková, M., Kim, H., Andhey, P. S., Duncan, D., Auclair, K., Chubukov, V., Simons, D. M., Roddy, T. P., Stewart, K. M., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0210-0 · Cited by 341
Metabolic orchestration of the wound healing response
Eming, S. A., Murray, P. J., & Pearce, E. J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.07.017 · Cited by 326
Macrophage Metabolism As Therapeutic Target for Cancer, Atherosclerosis, and Obesity
Geeraerts, X., Bolli, E., Fendt, S., & Ginderachter, J. A. V. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00289 · Cited by 326
Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy
Riera-Domingo, C., Audigé, A., Granja, S., Cheng, W.-C., Ho, P.-C., Baltazar, F., Stockmann, C., & Mazzone, M. (2020) · Physiological Reviews · doi:10.1152/physrev.00018.2019 · Cited by 310
Daniels, B. P., Kofman, S. B., Smith, J. R., Norris, G. T., Snyder, A. G., Kolb, J. P., Gao, X., Locasale, J. W., Martinez, J., Gale, M., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.11.017 · Cited by 305
Metabolic Modulation in Macrophage Effector Function
Diskin, C., & Pålsson‐McDermott, E. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00270 · Cited by 310
Olagnier, D., Brandtoft, A. M., Gunderstofte, C., Villadsen, N. L., Krapp, C., Thielke, A. L., Laustsen, A., Peri, S., Hansen, A. L., Bonefeld, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05861-7 · Cited by 282
Bailey, J. D., Diotallevi, M., NICOL, T., McNeill, E., Shaw, A., Chuaiphichai, S., Hale, A., Starr, A., Nandi, M., Stylianou, E., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.018 · Cited by 266
Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors
Weiss, J. M., Davies, L. C., Karwan, M., Ileva, L., Ozaki, M. K., Cheng, R. Y. S., Ridnour, L. A., Annunziata, C. M., Wink, D. A., & McVicar, D. W. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99169 · Cited by 267
Cancer cell and macrophage cross-talk in the tumor microenvironment
Dehne, N., Mora, J., Namgaladze, D., Weigert, A., & Brüne, B. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.04.007 · Cited by 270
Metabolic regulation of macrophage phenotype and function
Saha, S., Shalova, I. N., & Biswas, S. K. (2017) · Immunological Reviews · doi:10.1111/imr.12603 · Cited by 260
Papathanassiu, A. E., Ko, J., Imprialou, M., Bagnati, M., Srivastava, P. K., Vu, H., Cucchi, D., McAdoo, S. P., Ananieva, E. A., Mauro, C., et al. (2017) · Nature Communications · doi:10.1038/ncomms16040 · Cited by 258
Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis
Tabas, I. A., & Bornfeldt, K. (2020) · Circulation Research · doi:10.1161/circresaha.119.315939 · Cited by 253
How location and cellular signaling combine to activate the NLRP3 inflammasome
Akbal, A., Dernst, A., Lovotti, M., Mangan, M., McManus, R. M., & Latz, E. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00922-w · Cited by 259
Macrophage fumarate hydratase restrains mtRNA-mediated interferon production
Hooftman, A., Peace, C. G., Ryan, D. G., Day, E. A., Yang, M. H., McGettrick, A. F., Yin, M., Montano, E. N., Huo, L., Toller-Kawahisa, J. E., et al. (2023) · Nature · doi:10.1038/s41586-023-05720-6 · Cited by 258
Itaconate confers tolerance to late NLRP3 inflammasome activation
Bambousková, M., Potůčková, L., Paulenda, T., Kerndl, M., Mogilenko, D. A., Lizotte, K., Swain, A., Hayes, S., Sheldon, R. D., Kim, H., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108756 · Cited by 247
Tricarboxylic Acid (TCA) Cycle Intermediates: Regulators of Immune Responses
Choi, I., Son, H., & Baek, J.-H. (2021) · Life · doi:10.3390/life11010069 · Cited by 262
Kieler, M., Hofmann, M., & Schabbauer, G. (2021) · FEBS Journal · doi:10.1111/febs.15715 · Cited by 250
Nitric Oxide in Macrophage Immunometabolism: Hiding in Plain Sight
Palmieri, E. M., McGinity, C., Wink, D. A., & McVicar, D. W. (2020) · Metabolites · doi:10.3390/metabo10110429 · Cited by 237
“The rapid and profound increase of itaconate in stimulated macrophages [112], Nos2−/− cells bearing higher levels of itaconate with high fractional incorporation of glucose carbon at the expense of glutamine carbon, together with the sensitivity of inhibition of PDH and ACO2 to NO, all justify a new, corrected model f…”
BackgroundInfluentialThe Immunomodulatory Potential of the Metabolite Itaconate
Hooftman, A., & O'Neill, L. A. J. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.05.007 · Cited by 236
Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses
Chen, L., Morcelle, C., Cheng, Z., Chen, X., Xu, Y., Gao, Y., Song, J., Li, Z., Smith, M. D., Shi, M., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00853-8 · Cited by 234
ACOD1 in immunometabolism and disease
Wu, R., Chen, F., Wang, N., Tang, D., & Kang, R. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0489-5 · Cited by 223
The role of macrophages polarization in sepsis-induced acute lung injury
Wang, Z., & Wang, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1209438 · Cited by 235
Modification of Proteins by Metabolites in Immunity
Diskin, C., Ryan, T. A. J., & O'Neill, L. A. J. (2020) · Immunity · doi:10.1016/j.immuni.2020.09.014 · Cited by 215
Regulation of succinate dehydrogenase and role of succinate in cancer
Dalla Pozza, E., Dando, I., Pacchiana, R., Liboi, E., Scupoli, M. T., Donadelli, M., & Palmieri, M. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.04.013 · Cited by 212
Fleetwood, A. J., Lee, M. K. S., Singleton, W., Achuthan, A. A., Lee, M.-C., O’brien-simpson, N. M., Cook, A. D., Murphy, A. J., Dashper, S. G., Reynolds, E. C., et al. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00351 · Cited by 212
Self-citationMetabolism Supports Macrophage Activation
Langston, P. K., Shibata, M., & Horng, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00061 · Cited by 185
The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging
Meyers, A. K., & Zhu, X. (2020) · Cells · doi:10.3390/cells9081808 · Cited by 207
Molecular Mechanisms Modulating the Phenotype of Macrophages and Microglia
Amici, S. A., Dong, J., & Guerau‐de‐Arellano, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01520 · Cited by 200
Seim, G. L., Britt, E. C., John, S. V., Yeo, F. J., Johnson, A. R., Eisenstein, R. S., Pagliarini, D. J., & Fan, J. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0083-2 · Cited by 179
Chen, F., Elgaher, W. A. M., Winterhoff, M., Büssow, K., Waqas, S. F., Graner, E., Pires‐Afonso, Y., Perez, L. C., de la Vega, L., Sahini, N., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00577-x · Cited by 175
Self-citationMetabolic influence on macrophage polarization and pathogenesis
Thapa, B., & Lee, K. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.6.140 · Cited by 176
Impact of intracellular innate immune receptors on immunometabolism
Chou, W.-C., Rampanelli, E., Li, X., & Ting, J. P. ‐. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00780-y · Cited by 173
Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumour growth
Zhao, H., Teng, D., Yang, L., Xu, X., Chen, J., Jiang, T., Feng, A. Y., Zhang, Y., Frederick, D. T., Gu, L., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00676-9 · Cited by 179
Biphasic Dynamics of Macrophage Immunometabolism during Mycobacterium tuberculosis Infection
Shi, L., Jiang, Q., Bushkin, Y., Subbian, S., & Tyagi, S. (2019) · mBio · doi:10.1128/mbio.02550-18 · Cited by 173
Itaconate is an effector of a Rab GTPase cell-autonomous host defense pathway against Salmonella
Chen, M., Sun, H., Boot, M., Shao, L., Chang, S.-J., Wang, W., Lam, T. T., Lara-Tejero, M., Rego, E. H., & Galán, J. E. (2020) · Science · doi:10.1126/science.aaz1333 · Cited by 164
Dambrova, M., Zuurbier, C. J., Borutaitė, V., Liepinsh, E., & Makrecka‐Kuka, M. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.036 · Cited by 169
Marrocco, A., & Ortiz, L. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.936167 · Cited by 173
Itaconate controls the severity of pulmonary fibrosis
Ogger, P. P., Albers, G. J., Hewitt, R. J., O’Sullivan, B., Powell, J. E., Calamita, E., Ghai, P., Walker, S. A., McErlean, P. K., Saunders, P. T., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc1884 · Cited by 157
Shi, X., Zhou, H., Wei, J., Mo, W., Li, Q., & Lv, X. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102553 · Cited by 166
Inducible antibacterial responses in macrophages
Sweet, M. J., Ramnath, D., Singhal, A., & Kapétanovic, R. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01080-y · Cited by 171
Mitochondria reactive oxygen species signaling in immune responses
Weinberg, S. E., & Chandel, N. S. (2025) · Immunity · doi:10.1016/j.immuni.2025.07.012 · Cited by 175
Itaconate modulates tricarboxylic acid and redox metabolism to mitigate reperfusion injury
Cordes, T., Lucas, A., Divakaruni, A. S., Murphy, A. N., Cabrales, P., & Metallo, C. M. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.11.019 · Cited by 156
Self-citationSanta, F. D., Vitiello, L., Torcinaro, A., & Ferraro, E. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7420 · Cited by 157
The Human Knockout Gene CLYBL Connects Itaconate to Vitamin B12
Shen, H., Campanello, G. C., Flicker, D., Grabarek, Z., Hu, J., Luo, C., Banerjee, R. V., & Mootha, V. K. (2017) · Cell · doi:10.1016/j.cell.2017.09.051 · Cited by 150
Chen, Y., Li, G.-N., Li, X.-J., Wei, L.-X., Fu, M., Cheng, Z., Yang, Z., Zhu, G., Wang, X., Zhang, C., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg0654 · Cited by 152
Krebs cycle rewired for macrophage and dendritic cell effector functions
Ryan, D. G., & O'Neill, L. A. J. (2017) · FEBS Letters · doi:10.1002/1873-3468.12744 · Cited by 154
Targeting macrophage immunometabolism: Dawn in the darkness of sepsis
Kumar, V. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.005 · Cited by 150
Macrophages are metabolically heterogeneous within the tumor microenvironment
Geeraerts, X., Fernández-García, J., Hartmann, F. J., de Goede, K. E., Martens, L., Elkrim, Y., Debraekeleer, A., Stijlemans, B., Vandekeere, A., Rinaldi, G., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110171 · Cited by 151
PPARγ is a nexus controlling alternative activation of macrophages via glutamine metabolismPreprint
Nelson, V. L., Nguyen, H. C. B., García‐Cañaveras, J. C., Briggs, E. R., Ho, W. Y., DiSpirito, J. R., Marinis, J. M., Hill, D. A., & Lazar, M. A. (2018) · Genes & Development · doi:10.1101/gad.312355.118 · Cited by 147
Mitochondrial metabolites: undercover signalling molecules
Frezza, C. (2017) · Interface Focus · doi:10.1098/rsfs.2016.0100 · Cited by 136
Freemerman, A. J., Zhao, L., Pingili, A. K., Teng, B., Cozzo, A. J., Fuller, A. M., Johnson, A., Milner, J. J., Lim, M. F., Galanko, J. A., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800002 · Cited by 132
Metabolic programming of macrophage functions and pathogens control
Koo, S.-J., & Garg, N. J. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101198 · Cited by 135
Huang, H., Li, G., He, Y., Chen, J., Yan, J., Zhang, Q., Li, L., & Cai, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1404441 · Cited by 155
Food Fight: Role of Itaconate and Other Metabolites in Antimicrobial Defense
Luan, H. H., & Medzhitov, R. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.013 · Cited by 130
Dimethyl Itaconate Is Not Metabolized into Itaconate Intracellularly
ElAzzouny, M., Tom, C. T. M. B., Evans, C. R., Olson, L. L., Tanga, M. J., Gallagher, K. A., Martin, B. R., & Burant, C. F. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.c117.775270 · Cited by 125
Pålsson‐McDermott, E. M., & O'Neill, L. A. J. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.03.004 · Cited by 124
An Epigenetic Role of Mitochondria in Cancer
Liu, Y., Chen, C., Wang, X., Sun, Y., Zhang, J., Chen, J., & Shi, Y. (2022) · Cells · doi:10.3390/cells11162518 · Cited by 131
Macrophage metabolic reprogramming during chronic lung disease
Ogger, P. P., & Byrne, A. J. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00356-5 · Cited by 123
Mesaconate is synthesized from itaconate and exerts immunomodulatory effects in macrophages
He, W., Henne, A., Lauterbach, M., Geißmar, E., Nikolka, F., Kho, C., Heinz, A., Dostert, C., Grusdat, M., Cordes, T., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00565-1 · Cited by 119
Self-citationThe Metabolic Basis of Immune Dysfunction Following Sepsis and Trauma
McBride, M. A., Owen, A. M., Stothers, C. L., Hernandez, A., Luan, L., Burelbach, K. R., Patil, T. K., Bohannon, J. K., Sherwood, E. R., & Patil, N. K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01043 · Cited by 120
The Dynamic Inflammatory Tissue Microenvironment: Signality and Disease Therapy by Biomaterials
Mata, R., Yao, Y., Cao, W., Ding, J., Zhou, T., Zhai, Z., & Gao, C. (2021) · Research · doi:10.34133/2021/4189516 · Cited by 116
Kuo, P., Weng, W., Scofield, B. A., Paraiso, H. C., Brown, D. A., Wang, P., Yu, I.-C. I., & Yen, J.-H. J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01768-7 · Cited by 113
Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming
D’Alessandro, A., Kasmi, K. C. E., Plecitá‐Hlavatá, L., Ježek, P., Li, M., Zhang, H., Gupte, S. A., & Stenmark, K. R. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7217 · Cited by 111
Biochemistry of proinflammatory macrophage activation
Nonnenmacher, Y., & Hiller, K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2784-1 · Cited by 112
Self-citationSohail, A., Iqbal, A., Sahini, N., Chen, F., Tantawy, M. A., Waqas, S. F., Winterhoff, M., Ebensen, T., Schultz, K., Geffers, R., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010219 · Cited by 107
Self-citationIntegrated Molecular Characterization of Fumarate Hydratase–deficient Renal Cell Carcinoma
Sun, G., Zhang, X., Liang, J., Pan, X., Zhu, S., Liu, Z., Armstrong, C. M., Chen, J., Lin, W., Liao, B., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3788 · Cited by 102
Bettencourt, I. A., & Powell, J. D. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601318 · Cited by 106
Local Treatment with Lactate Prevents Intestinal Inflammation in the TNBS-Induced Colitis Model
Iraporda, C., Romanin, D., Bengoa, A. A., Errea, A. J., Cayet, D., Foligné, B., Sirard, J., Garrote, G. L., Abraham, A. G., & Rumbo, M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00651 · Cited by 106
Alam, M. S., & Czajkowsky, D. M. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.11.001 · Cited by 111
Staphylococcus aureus stimulates neutrophil itaconate production that suppresses the oxidative burst
Tomlinson, K. L., Riquelme, S. A., Baskota, S. U., Drikic, M., Monk, I. R., Stinear, T. P., Lewis, I. A., & Prince, A. S. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112064 · Cited by 103
Zhu, X., Guo, Y., Liu, Z., Yang, J., Tang, H., & Wang, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-97352-x · Cited by 107
4-octyl itaconate as a metabolite derivative inhibits inflammation via alkylation of STING
Li, W., Li, Y., Kang, J., Jiang, H., Gong, W., Chen, L., Wu, C., Liu, M., Wu, X., Zhao, Y., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112145 · Cited by 117
Léveillard, T., Philp, N. J., & Sennlaub, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030762 · Cited by 103
Metabolic Regulation in the Induction of Trained Immunity
Ferreira, A. V., Domínguez‐Andrés, J., Pich, L. M. M., Joosten, L. A. B., & Netea, M. G. (2024) · Seminars in Immunopathology · doi:10.1007/s00281-024-01015-8 · Cited by 104
Chen, F., Lukat, P., Iqbal, A., Saile, K., Kaever, V., van den Heuvel, J., Blankenfeldt, W., Büssow, K., & Peßler, F. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908770116 · Cited by 95
Metadata
- Authors
- Cordes, T., Wallace, M., Michelucci, A., Divakaruni, A. S., Sapcariu, S. C., Sousa, C., Koseki, H., Cabrales, P., Murphy, A. N., Hiller, K., & Metallo, C. M.
- Affiliations
- University of California San Diego (US)
- University of Luxembourg (LU)
- RIKEN Center for Integrative Medical Sciences (JP)
- Corresponding author
- Metallo, Christian M.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 291
- Issue
- 27
- Pages
- 14274-14284
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC4933182
- OpenAlex
- W2361586644
- Semantic Scholar
- e5517dd16c4dff72218eace800e1b0913a233bce
- Cited by
- 526
- References
- 52
- Citations by year
- 2026: 55 · 2025: 60 · 2024: 68 · 2023: 55 · 2022: 58 · 2021: 69 · 2020: 64 · 2019: 42 · 2018: 27 · 2017: 23 · 2016: 5
- FWCI
- 19.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (R01CA188652, P01DK054441)
- National Institute of Allergy and Infectious Diseases (R01AI082610)
- National Heart, Lung, and Blood Institute (R53HL123015, P01HL110900, R01HL052684)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Microbial metabolism and enzyme function
- Keywords
- IRG1, itaconate, succinate accumulation, succinate dehydrogenase inhibition, cis-aconitate decarboxylase, TCA cycle, metabolic reprogramming, innate immunity, macrophages, lipopolysaccharide, electron transport chain, immunometabolism
- MeSH terms
- Animals, Cell Line, Hydro-Lyases, Lipopolysaccharides, Macrophages, Succinate Dehydrogenase, Succinates, Succinic Acid, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
